Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study.
- DOI
- 10.1002/cam4.71982
- Published
- 2026 May
- Container
- Cancer medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.71982,
title = {Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study.},
author = {Sonehara K and Tsutsui T and Nozawa S and Agatsuma T and Yamamoto M and Matsuo A and Nakanishi M and Chiaki T and Kato A and Miyahara T and Hachiya T and Kanda S and Hirabayashi T and Yanagisawa K and Araki T and Tateishi K and Hanaoka M},
year = {2026},
journal = {Cancer medicine},
doi = {10.1002/cam4.71982},
url = {https://doi.org/10.1002/cam4.71982}
}RIS
TY - JOUR TI - Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study. AU - Sonehara K AU - Tsutsui T AU - Nozawa S AU - Agatsuma T AU - Yamamoto M AU - Matsuo A AU - Nakanishi M AU - Chiaki T AU - Kato A AU - Miyahara T AU - Hachiya T AU - Kanda S AU - Hirabayashi T AU - Yanagisawa K AU - Araki T AU - Tateishi K AU - Hanaoka M PY - 2026 JO - Cancer medicine DO - 10.1002/cam4.71982 UR - https://doi.org/10.1002/cam4.71982 ER -
APA
K, S., T, T., S, N., T, A., M, Y., A, M., M, N., T, C., A, K., T, M., T, H., S, K., T, H., K, Y., T, A., K, T., & M, H. (2026). Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study.. Cancer medicine. https://doi.org/10.1002/cam4.71982
Source records
- pubmed · retrieved 2026-09-25T10:09:39.137Z